CLINICAL ROLE -
HCV Drug Harvoni Updated to Include Recommendations for HIV
Antiretroviral drug interactions now included due to high prevalence of HIV coinfection among patients with hepatitis C virus.
Read More
FDA Grants Multiple Myeloma Drug Accelerated Approval
Daratumumab is a single agent for multiple myeloma in patients who previously received at least 3 lines of therapy.
HIV Drug Access Limited for Patients in Exchange Plans
Study finds many silver plans have higher out-of-pocket costs for most the commonly prescribed HIV treatments.
New Drug Application Submitted for Leukemia Treatment
Approval sought for Imbruvica combination for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Medication Management in Inflammatory Bowel Disease
Marc O'Connor, chief operating officer of Curant Health, discusses counseling patients on a therapeutic regimen for IBD.
Dead Bacteria May Prove to be Effective Cancer Killer
Clostridium sporogenes bacteria able to eradicate colon cancer tumor cells.
FDA Approves Longer Lasting New Treatment for Hemophilia A
Modified version of Adynovate lasts longer in the blood for less frequent injections.
First Line HIV Therapy Associated with Acute Kidney Injury
HIV drug Tenofovir may carry a risk of nephrotoxicity.
Approvals of New Lung Cancer, Melanoma Drugs Highlight Specialty Pharmacy Week in Review
Top stories of the week on Specialty Pharmacy Times.
FDA Grants Lung Cancer Drug Accelerated Approval
Osimertinib (Tagrisso) is a once daily tablet for patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.
Novel Rheumatoid Arthritis Drug Shows Improvement in Symptoms
Treatment with sarilumab improves RA signs, symptoms, and physical function.
Wealth Trumps Need in Organ Transplant Decisions
Patients simultaneously registering at multiple centers had higher transplant rates, lower death rates waiting for a transplant, and greater income.
Psoriatic Arthritis Treatment Shows No Joint Damage Progression
Cosentyx found to maintain improvements in joint and skin disease, physical function, and quality of life in PsA patients.
Cancer Wreaks Havoc on More Than Just Physical Health
Patients with cancer see a decline in employment, hours worked, individual income, and total family income following diagnosis.
How Medical Marijuana May Impact Specialty Pharmacy
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the development of medical marijuana within the specialty space.
Could Hepatitis C Be Cured in Less Than a Month?
HCV drug combination may cut treatment time by 75%.
FDA Approves New Combo for Advanced Melanoma
Combination of Cotellic and Zelboraf shows superior overall and progression free survival in melanoma treatment.
Breast Cancer Stem Cells May Lead to Improved Treatments
Newly discovered pathway may prove effective target for treatment of triple-negative breast cancer.
Oral Proteasome Inhibitor Shows Promise in Multiple Myeloma
Once-a-week treatment is the first oral proteasome inhibitor to reach late stage clinical development.
Accountable Care Organization Goals and Specialty Pharmacy
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses the alignment between specialty pharmacies and ACOs.
FDA Says Blood Thinner Does Not Increase Cancer Risk
Benefits of Plavix found to outweigh potential adverse events.
Inflammatory Bowel Disease Treatment Success Influenced by Serum Levels
Serum levels may determine impact of anti-tumor necrosis factor drugs.
Researchers Seek to Control Multiple Sclerosis Progression
Study may lead to vaccines that force an immune response.
Researchers May Soon Predict Drug Side Effects on Different Patients
Researchers seek to determine which side effects will be experienced by different patient groups.
FDA Approvals and Breakthroughs Highlight Specialty Pharmacy Week in Review
Specialty Pharmacy in the Affordable Care Act Era
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses how the ACA has impacted the specialty landscape.
FDA Approves Single Tablet HIV Treatment
Gilead's Genvoya is the first TAF-based regimen approved by the FDA.
Study Finds Media Inflates Potential of Cancer Drugs
Terms like revolutionary or miracle cause confusion for readers.
Oral Inflammatory Bowel Disease Drug Closer to Reality
Biofilm proteins show promise in treatment of gastrointestinal disorders.
FDA Approves New Severe Asthma Treatment
Nucala is for use with other asthma drugs for the maintenance of patients 12 years and older.